Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove …,

Takeda will be discussing these data with the U.S. Food and Drug Administration (FDA). The complete primary analysis of the OPTIC trial will be …, Takeda will be discussing these data with the U.S. Food and Drug Administration (FDA). The complete primary analysis of the OPTIC trial will be …, Read More

Scroll to Top